Daiwa Securities Group Inc. Buys 2,849 Shares of Cencora, Inc. $COR

Daiwa Securities Group Inc. boosted its stake in shares of Cencora, Inc. (NYSE:COR) by 9.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 32,629 shares of the company’s stock after purchasing an additional 2,849 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Cencora were worth $11,021,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in COR. Norges Bank bought a new stake in Cencora during the fourth quarter valued at about $822,506,000. Marshall Wace LLP boosted its position in Cencora by 518.9% during the third quarter. Marshall Wace LLP now owns 1,995,118 shares of the company’s stock valued at $623,534,000 after purchasing an additional 1,672,762 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Cencora by 528.9% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,475,859 shares of the company’s stock valued at $461,250,000 after purchasing an additional 1,241,186 shares in the last quarter. Viking Global Investors LP boosted its position in Cencora by 95.0% during the second quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after purchasing an additional 1,013,913 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in Cencora by 4.1% during the third quarter. Vanguard Group Inc. now owns 23,395,547 shares of the company’s stock valued at $7,311,810,000 after purchasing an additional 916,506 shares in the last quarter. Institutional investors own 97.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Wells Fargo & Company decreased their price target on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. UBS Group increased their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. increased their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Finally, Evercore set a $360.00 price target on Cencora in a research note on Wednesday, April 8th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $380.25.

Cencora Trading Up 1.7%

Cencora stock opened at $274.94 on Friday. The stock has a 50-day moving average of $292.70 and a two-hundred day moving average of $330.55. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The stock has a market cap of $53.49 billion, a PE ratio of 21.08, a price-to-earnings-growth ratio of 1.48 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the business posted $4.42 earnings per share. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts anticipate that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora declared that its Board of Directors has initiated a stock repurchase program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

Cencora Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is presently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.